e-SPACE Heart Failure 2024
Published: 28 October 2024
-
Views:
175 -
Likes:
7
-
Views:
175 -
Likes:
7
-
Up Next
-
59m 41sPart 2 | Session 3 Plenary session 9 – Managing HFpEF in 2024
-
1h 45sPart 2 | Session 4 Plenary session 10 – Valvular heart disease
-
59m 47s
-
1h 57sPart 1 | Session 1 Plenary session 1 – Practical implementation of GDMT in the clinical setting Vijay Chopra, Tarek Bekfani, Gianluigi Savarese, Jasper J Brugts, Justin Ezekowitz
-
1h 2m 9sPart 1 | Session 2 Plenary session 2 – SGLT2s in clinical practice John J Atherton, Tarek Bekfani, Javed Butler, Clara Saldarriaga, Faiez Zannad
-
1h 7m 6sPart 1 | Session 3 Special session 1 – Cardiac rhythm management devices: cornerstones of comprehensive, patient-centred HF care The-DIRECT-HF initiative (The DIRECT HF educational programme is supported by Medtronic) Biykem Bozkurt, Javed Butler, Giuseppe Rosano, Gianluigi Savarese, Shelley Zieroth
-
59m 29sPart 1 | Session 4 Plenary session 3 – Obesity and weight management in HF Stefan Anker, Petar M Seferovic, Naveed Sattar, Shelley Zieroth, Shahzeb Khan, Peter Rossing
-
28m 30sPart 1 | Session 5 Special session 2 – Face to face with cardiac amyloidosis Thibaud Damy
-
1h 10m 15sPart 1 | Session 6 Plenary session 4 – Managing cardiomyopathy in HF Arnt Kristen, Carsten Tschöpe, Michelle Kittleson, Marianna Fontana
-
1h 4m 48sPart 1 | Session 7 Plenary session 5 – Cardiac rhythm in HF Andrea Russo, Fausto J Pinto, Klaus Witte, Carsten W Israel, William T Abraham, Reinoud Knops
-
1h 13m 18sPart 1 | Session 8 Plenary session 6 – Devices in HF; time to reassess their place? Ileana L Piña, Stefan Anker, David Duncker, Marat Fudim, Dirk Westermann, William T Abraham
-
58m 32sPart 2 | Session 1 Plenary session 7 – Enabling GDMT in HF David Sim, Alicia Chan, Gianluigi Savarese, Gerasimos Filippatos, João Pedro Ferreira
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.
e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts are incorporating heart failure guidelines into clinical practice and offered the latest information on patient profiling in heart failure for tailored medical therapy.
Building on the tremendous success of previous years, this event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Heart Failure 2024:
- Meet the Experts: SGLT2 Inhibitors in Real Life: Everything the Clinician Needs to Know
- Meet the Experts: GDMT Implementation in HF: How to Tackle Clinical Inertia?
- Meet the Experts: Management of Transthyretin Amyloid Cardiomyopathy (ATTRCM): Optimising Patient Pathways
- Meet the Experts: IV Iron in Clinical Practice: Experts’ Perspectives
- Meet the Experts: Hyperkalemia in HF: Clinical Impact and Long-term Management
- Symposium: SGLT2 Inhibitors in Heart Failure: Updates on Prevention and Treatment
- Meet the Experts: Non-steroidal MRAs: Evolving Role in Heart Failure
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Mitja Lainscak
Professor, Division of Cardiology
Prof Mitja Lainscak is a Professor in the Division of Cardiology at University of Ljubljana, Ljubljana, SI. He is also Director of the Slovenian Research Agency.
Gianluigi Savarese
Associate Professor of Cardiology
Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018.
Prof Savarese has…
Ewa Jankowska
Prof Ewa Jankowska is Professor of Medicine and Head of Laboratory of Applied Research on Cardiovascular System at the Department of Heart Diseases, Wroclaw Medical University, Poland. Her clinical and research interests include the role of peripheral mechanisms in the progression of heart failure, co-morbidities in heart failure, and experimental model of tachycardia-induced cardiomyopathy.
Prof Jankowska is an Editorial Board member of Cardiac Failure Review.
Paul Kalra
Professor
Prof Paul Kalra is Professor of Cardiology at Portsmouth Hospitals NHS Trust, UK. The majority of his work involves assessment, investigation and management of patients with known or suspected cardiac problems. While he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. Prof Kalra has championed local heart failure service development and co-developed the local complex device service, initiating implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy device (CRT) implantation and follow up. He has extensive experience in assessment of patients for consideration of and the implantation of pacemakers and complex devices (CRT and ICD).
Elected Chair of the British Society for Heart Failure (BSH) 2017-2019. In 2019 the Pumping Marvellous Foundation, presented Prof Kalra with the Platinum patient educator award – recognising…
John GF Cleland
Professor of Cardiology
Prof John Cleland is a Professor of Cardiology at University of Glasgow, Glasgow, UK.
In 1977, he qualified from the University of Glasgow, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation.
His main interests include heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines.
He founded the European Journal of Heart Failure and is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure.